Updates are available Correction dated 2025-05-14

Article History

Received: 3 May 2024

Accepted: 17 March 2025

First Online: 27 March 2025

Change Date: 12 May 2025

Change Type: Update

Change Details: The original version of this article was revised: the authors identified an error in Fig. 2

Change Date: 14 May 2025

Change Type: Correction

Change Details: A Correction to this paper has been published:

Change Details: https://doi.org/10.1186/s12882-025-04152-w

Declarations

:

: All data were extracted from the Fresenius Kidney Care clinical data warehouse and de-identified. The study was determined to be exempt under 45 CFR § 46.104(d)(4) by an independent institutional review board (New England Institutional Review Board [NEIRB], Needham, MA, USA; WCG IRB Work Order #1-1650918-1).

: Not applicable.

: Linda H. Ficociello is employee of Renal Research Institute LLC, a wholly owned subsidiary of Fresenius Medical Care Holdings Inc. and has ownership interest in Fresenius Medical Care. Rachel Lasky is employee of Renal Research Institute LLC. Hans-Juergen Arens and Michael S. Anger are employees of and have stock/ownership interest in Fresenius Medical Care. Despina Ruessmann is an employee of and has ownership interest in CSL Vifor.